Technology | Radiation Dose Management | May 23, 2019

ControlRad Announces FDA Clearance and Launch of ControlRad Trace

Radiation reduction technology integrates directly into mobile C-arms

ControlRad Announces FDA Clearance and Launch of ControlRad Trace

May 23, 2019 — ControlRad Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its ControlRad Trace and the company has initiated its commercial launch. The ControlRad Trace is the only technology, according to the company, that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.

“Radiologists and our teams have grave concerns about the long-term effects from radiation exposure,” said John A. Carrino, M.D., MPH, vice chairman of radiology, Hospital for Special Surgery. “I am excited that new technology for mobile C-arms is now available because it has the potential to drastically improve our radiation safety while maintaining image quality so we can continue to effectively diagnose and treat our patients. I believe these new products should become the standard of care for fluoroscopic procedures.”

Fluoroscopically guided procedures (FGP) with C-arms have allowed for major advances in treating countless diseases. However they expose patients and medical staff to ionizing radiation, which may increase a person’s lifetime risk of developing cancer.1 For example, an interventional fluoroscopy procedure is roughly equivalent to the adult effective dose of between 250-3,500 chest X-rays.2

With its proprietary semi-transparent filter, tablet and image processing technology, the ControlRad Trace solution can be retrofitted on existing C-arms, reducing the barrier to adopting the technology in order to reduce unnecessary radiation up to 89 percent,3 without compromising image quality in the region of interest (ROI) and overall workflow. The medical staff draws an ROI on a ControlRad tablet, which in real time optimizes image quality in the ROI while reducing unnecessary radiation in the periphery.

For more information: www.controlrad.com

References

1.  https://www.fda.gov/radiation-emitting-products/initiative-reduce-unnecessary-radiation-exposure-medical-imaging/white-paper-initiative-reduce-unnecessary-radiation-exposure-medical-imaging, p. 1

2. Ibid, p. 3

3. Data on file

Related Content

Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
Expert medical organizations caution that evidence-based ordering of medically necessary imaging exams should not be denied due to widely disagreed upon radiation dose levels tracked in some electronic health record systems (EHRs).
News | Radiation Dose Management | August 17, 2021
August 17, 2021 — Expert medical organizations caution that evidence-based ordering of medically necessary imaging ex
#coronavirus #COVID19 #pandemic #RSNA21 will require all attendees and exhibitors to show proof of #vaccination and wear a #mask

Getty Images

News | RSNA | August 12, 2021
August 12, 2021 — RSNA 2021 will require proof of CO...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity.

Axial reformatted clinical (1.083 mSv) and reduced dose (0.318 mSv) CT images from a 17-year-old girl with osteosarcoma. A 2 mm left lower lobe nodule is clearly visible in the left lower lobe on the clinical CT image (arrow in A). The same nodule is vaguely apparent on the reduced-dose CT image (arrow in B), classified as present but poorly visible.

News | Computed Tomography (CT) | July 09, 2021
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Mobile C-Arms | July 07, 2021 | By Bhvita Jani
With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resource
Studies conducted by Mass General Hospital and University of Virginia have concluded that PixelShine, a disruptive technology from AlgoMedica, significantly improved the diagnostic quality of CT scans acquired at reduced radiation dose. Here, you can see before and after noise reduction is applied.

Studies conducted by Mass General Hospital and University of Virginia have concluded that PixelShine, a disruptive technology from AlgoMedica, significantly improved the diagnostic quality of CT scans acquired at reduced radiation dose. Here, you can see before and after noise reduction is applied.

Feature | Computed Tomography (CT) | July 02, 2021 | By Mikael Strindlund
Turner Imaging Systems, a developer of advanced X-ray imaging systems, announced the company has received its CE Mark for its Smart-C Mini C-Arm portable fluoroscopy x-ray imaging device.
News | Mobile C-Arms | June 01, 2021
June 1, 2021 — Turner Imaging Systems, a developer of advanced...